These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 9870249)

  • 1. Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD).
    Nalesnik MA
    Springer Semin Immunopathol; 1998; 20(3-4):325-42. PubMed ID: 9870249
    [No Abstract]   [Full Text] [Related]  

  • 2. EBV-induced post-transplant lymphoproliferative disorder (PTLD).
    Birkeland SA; Hamilton-Dutoit S; Sandvej K; Andersen HM; Bendtzen K; Møller B; Jørgensen KA
    Transplant Proc; 1995 Dec; 27(6):3467-72. PubMed ID: 8540055
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-transplant lymphoproliferative disorder.
    Basgoz N; Preiksaitis JK
    Infect Dis Clin North Am; 1995 Dec; 9(4):901-23. PubMed ID: 8747772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders.
    Rustgi VK
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):100-8. PubMed ID: 9346606
    [No Abstract]   [Full Text] [Related]  

  • 5. The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease.
    Hsieh WS; Lemas MV; Ambinder RF
    Transpl Infect Dis; 1999 Sep; 1(3):204-12. PubMed ID: 11428990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.
    Leblond V; Sutton L; Dorent R; Davi F; Bitker MO; Gabarre J; Charlotte F; Ghoussoub JJ; Fourcade C; Fischer A
    J Clin Oncol; 1995 Apr; 13(4):961-8. PubMed ID: 7707124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants].
    Hidalgo M; Lumbreras C; Aguado JM
    Med Clin (Barc); 1996 Sep; 107(8):310-6. PubMed ID: 8965496
    [No Abstract]   [Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoproliferative disease in organ transplant recipients.
    Nalesnik MA
    Springer Semin Immunopathol; 1991; 13(2):199-216. PubMed ID: 1664986
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation.
    Montone KT; Litzky LA; Wurster A; Kaiser L; Bavaria J; Kotloff R; Palevsky H; Pietra GG; Tomaszewski JE
    Surgery; 1996 May; 119(5):544-51. PubMed ID: 8619211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.
    Nalesnik MA; Starzl TE
    Transplant Sci; 1994 Sep; 4(1):61-79. PubMed ID: 7804700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
    Johnson LR; Nalesnik MA; Swerdlow SH
    Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransplantation lymphoproliferative disorders (PTLD): current perspectives.
    Nalesnik MA
    Semin Thorac Cardiovasc Surg; 1996 Apr; 8(2):139-48. PubMed ID: 8672567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management.
    Su IJ; Wang CH; Cheng AL; Chen RL
    Leuk Lymphoma; 1995 Nov; 19(5-6):401-6. PubMed ID: 8590839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.
    Capello D; Berra E; Cerri M; Gaidano G
    Minerva Med; 2004 Feb; 95(1):53-64. PubMed ID: 15041926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease.
    Swerdlow SH
    Histopathology; 1992 May; 20(5):373-85. PubMed ID: 1316870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl6/Laz3 rearrangements in post-transplant lymphoproliferative disorders.
    Delecluse HJ; Rouault JP; Jeammot B; Kremmer E; Bastard C; Berger F
    Br J Haematol; 1995 Sep; 91(1):101-3. PubMed ID: 7577614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous implantation of human post-transplant lymphoproliferative disease lesions in SCID mice.
    Randhawa PS; Pietrzak B; Nalesnik MA; Demetris AJ; Locker J
    Hematol Oncol; 1997 Feb; 15(1):39-46. PubMed ID: 9378472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders.
    Chetty R; Biddolph S; Kaklamanis L; Cary N; Stewart S; Giatromanolaki A; Gatter K
    J Pathol; 1996 Nov; 180(3):254-8. PubMed ID: 8958801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.